KMID : 1036020220110030272
|
|
ÁöÁú.µ¿¸Æ°æÈÇÐȸÁö 2022 Volume.11 No. 3 p.272 ~ p.279
|
|
Shinjulactone A Blocks Vascular Inflammation and the Endothelial-Mesenchymal Transition
|
|
Jang Ye-Eun
Immanuel Jenita Lee Jin-Ri Jang Yu-Jin Kwon Yun-Ju Kwon Hyun-Sook Shin Jung-Woog Yun Sang-Uk
|
|
Abstract
|
|
|
Objective: The endothelial inflammatory response plays an important role in atherogenesis by inducing nuclear factor (NF)¥êB-dependent cell adhesion molecule expression and monocyte recruitment. Here, we screened for natural ligands and investigated the ability of shinjulactone A to inhibit interleukin-1¥â (IL-1¥â)-induced endothelial inflammatory signaling.
Methods: The natural compound library included 880 single compounds isolated from medicinal plants by the Korean Medicinal Material Bank. Primary endothelial cells were pretreated with single compounds before stimulation with IL-1¥â to induce endothelial inflammation. Endothelial inflammation was measured by assaying NF¥êB activation and monocyte adhesion. The endothelial-mesenchymal transition (EndMT) was evaluated using cell type-specific marker protein expression and morphology.
Results: Shinjulactone A was identified as an efficient blocker of IL-1¥â -induced NF¥êB activation, with a half-maximal inhibitory concentration of approximately 1 ¥ìM, and monocyte recruitment in endothelial cells. However, it did not affect lipopolysaccharide-induced NF¥êB activation in macrophages. Compared to Bay 11-782, a well-known NF¥êB inhibitor that shows considerable cytotoxicity during long-term treatment, shinjulactone A did not affect endothelial cell viability. Furthermore, it also significantly inhibited the EndMT, which is known to promote atherosclerosis and plaque instability.
Conclusion: We suggest that shinjulactone A may be an effective and safe drug candidate for atherosclerosis because it targets and inhibits both endothelial inflammation and the EndMT, without impairing NF¥êB-dependent innate immunity in macrophages.
|
|
KEYWORD
|
|
Inflammation, Atherosclerosis, Endothelial cells
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|